News April 2015
2nd International Conference on Polymyxins
After ICAAC/ICC 2015, we invite you to attend the 2nd International Conference on Polymyxins to learn of the latest achievements on all major aspects of the polymyxin antibiotics.
Colistin and polymyxin B are last therapeutic options for treatment of life-threatening infections caused by Gram-negative ‘superbugs', namely Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. Since the 1st International Conference on Polymyxins in 2013 (Prato, Italy), significant progress has been made in the clinical use and pharmacology of polymyxins, in particular PK/PD/TD and nephrotoxicity, and discovery of novel polymyxin-like antibiotics.
News November 2014
The results of the Polymyxin conference in Prato, Italy, May 2013 have been published in Lancet Infectious Diseases:
RL Nation, J Li, O. Cars, W. Couet, MN Dudley, KS Kaye, JW Mouton, DL Paterson, VH Tam, U. Theuretzbacher, BT Tsuji, JD Turnidge: Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus